Esketamine Sedation and Fentanyl Sedation in Pediatric Dental Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

February 28, 2022

Study Completion Date

March 12, 2022

Conditions
KetamineFentanylSedation Complication
Interventions
DRUG

Fentanyl

"The fentanyl group was prepared by 1ug/kg fentanyl in 5ml normal saline, assembled with 5ml injection, labeled as Anesthesia inducer."

DRUG

Esketamine

"The esketamine group was prepared by 0.5mg/kg esketamine in 5ml normal saline, assembled with 5ml injection, labeled as Anesthesia inducer."

DRUG

Midazolam

"Midazolam 0.05mg/kg+ Anesthesia inducer was applied to all patients for procedural induction by intravenous injection. According to the MOAA/S score of the patients, midazolam could be added 0.5mg per time at more than 2 minutes until the MOAA/S score reached 3, the maximum infusion dose of midazolam was less than 10mg and less than 0.1mg/kg."

Trial Locations (1)

100081

Peking University Hospital of Stomatology, Beijing

All Listed Sponsors
lead

Peking University

OTHER

NCT04597320 - Esketamine Sedation and Fentanyl Sedation in Pediatric Dental Patients | Biotech Hunter | Biotech Hunter